RIXUBIS

takeda canada inc🇨🇦 Health Canada

Approval Id: ccfeed6386387d6f
Drug Approval Canada Name: RIXUBIS
Product Name: RIXUBIS
Status: Dormant
Status Date: 2024-11-06
Original Market Date: 2019-01-15
Din: 02431920
Drug Class: Human
Dosage Form: Kit , Powder For Solution
Route Of Administration: Intravenous
Schedule: Schedule D
Ahfs: 20:28.16
Atc Original: B02BD04 COAGULATION FACTOR IX
Atc Name: b 02 bd 04
Aig Number: 0156050001
Company Name: takeda canada inc
Company Address: 3800, 22 Adelaide Street West, Toronto, Ontario, Canada, M5H 4E3

NONACOG GAMMA

250 UNIT / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ccfeed6386387d6f

Type

Standard